Inovio Pharmaceuticals, Inc.INONASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+612.9%
5Y CAGR+287.8%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+612.9%/yr
vs +32.4%/yr prior
5Y CAGR
+287.8%/yr
Recent acceleration
Acceleration
+580.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
877.4x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $32.68B | +88234.6% |
| 2024 | $37.00M | -22.2% |
| 2023 | $47.58M | -47.2% |
| 2022 | $90.19M | +67.8% |
| 2021 | $53.75M | +44.3% |
| 2020 | $37.25M | +36.9% |
| 2019 | $27.20M | -7.2% |
| 2018 | $29.32M | +3.6% |
| 2017 | $28.29M | +18.4% |
| 2016 | $23.89M | - |